Form D · Pharmaceuticals
QUARK PHARMACEUTICALS INC
Fremont, CA · CIK 0000920189
Offering snapshot reported Jun 1, 2010 · SEC filing
- Reported sold
- $10M Offering amount: $10M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 17, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 1, 2010 | Initial | $10,000,000 | No comparison | 9 | SEC filing |
| Apr 8, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 11, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired, Other
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-142737
Series H Preferred Stock, warrants to purchase Series H Preferred Stock and underlying shares of Common Stock.
Source: Form D, filed Jun 1, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Carlos Benaim, M.Sc. | Executive |
| Shai Erlich, Ph.D. | Executive |
| Elena Feinstein, Ph.D. | Executive |
| Juliana Friedmann, M.Sc. | Executive |
| Trent M. Gunter | Director |
| Philip M. Hahn | Director |
| Robert L. Jones | Executive |
| Kazuyuki Matsui | Director |
| Toru Mio | Director |
| Smadar Shakked | Executive |
| Philip B. Simon | Director |
| Rami Skaliter | Executive |
| Peter A. Thompson, M.D. | Director |
| James D. Thompson, Ph.D. | Executive |
| Daniel Zurr, Ph.D. | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
6501 Dumbarton Circle
Fremont, CA, 94555
Fremont, CA, 94555